Contract HHSN275201100365P
Repligen Corporation · Department Of Health And Human Services · August 24, 2011
Repligen Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 24, 2011 for $5,000 of work in biological product (except diagnostic) manufacturing. Performance is in Bethesda, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSN275201100365P
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Bethesda, MD
- First action
- August 24, 2011
Description
REPLIGEN CORPORATION [11-013627] CAN 8383165
Modification timeline
-
August 24, 2011Base award$5.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN275201100365P?
Contract HHSN275201100365P is a federal contract awarded to Repligen Corporation by Department Of Health And Human Services on August 24, 2011 for $5,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSN275201100365P?
Repligen Corporation won contract HHSN275201100365P from Department Of Health And Human Services.
How much is contract HHSN275201100365P worth?
Contract HHSN275201100365P has obligated $5,000 to date.